Previously, GLP-1 medications which mimic the naturally occurring hormone glucagon-like peptide-1, which regulates blood sugar, digestion, and hunger had been approved only to treat obesity in the form of weekly, home-administered injections
A Key Tool for Weight Loss and Obesity Treatment As a medication, semaglutide mimics glucagon-like peptide-1 (GLP-1)
Employers have a real opportunity to step in, offer these treatments affordably and with dignity, and position themselves as employers of choice. While weighing the choice to cover GLP-1s, employer cost is a significant consideration, Midlam noted
This new drug can be even more effective for weight loss and blood sugar control
"Which gave me access to a life-saving, life-altering medication," she said